Moreover, the presence of CD8+ T-cells has been linked to considerable reductions in the relative risks of death from different subtypes of breast cancer [26]; and in ER-negative cancers, CD4+ and CD8+ T lymphocytes are more closely related to better outcomes than in ER-positive tumors [27]. The gene discussed is CD4; the disease is breast cancer.